fda blenrep - Search News

Order byBest matchMost fresh

News

GSK, Blenrep and FDA

Zacks Investment Research on M… · 1h

FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

GSK plc GSK announced that the FDA’s Oncologic Drugs Advisory Committee (ODAC) has voted against the overall benefit/risk profile of the Blenrep (belantamab mafodotin-blmf) combination therapy at the proposed dosing regimen.

Continue reading

· 17h · on MSN

FDA Committee Votes Against GSK Blood Cancer Drug Blenrep

Pharmaceutical Technology · 38m

GSK’s Blenrep faces setback as FDA cancer committee votes against approval

Pharmalittle: We’re reading about a GSK setback, another Sarepta gene therapy death, and more

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

GSK’s Blenrep Loses Adcomm Vote, Further Clouding Comeback Bid

The panelists flagged safety concerns with Blenrep and GSK’s failure to optimize its dosing regimen for the antibody-drug ...

8hon MSN

GSK Shares Fall After Blood Cancer Drug Likely Headed for U.S. Rejection

The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage ...

Fierce Pharma3d

As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results